Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | Director | May 29, 2026 | June 02, 2026 |
| NORTHROP GRUMMAN CORP /DE/NOC · Entity 2963 | Director · Chair, CEO and President | August 19, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 17,890.2917 |
Reported balance
After 2026-05-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-29 · Grant · Acquired 1,853.0997 · Balance 17,890.2917 F1: 1-for-1 F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3: Holdings include shares acquired in dividend reinvestment transactions. |
| Common StockSEC Table I · non-derivative | Direct | 500 |
Reported balance
Holding disclosure · report date 2026-05-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 500 |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3: Holdings include shares acquired in dividend reinvestment transactions.
NORTHROP GRUMMAN CORP /DE/
Report date August 19, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Market Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,910 |
Reported balance
After 2026-08-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-19 · Grant · Acquired 35,910 · Balance 35,910 F1: Each Market Stock Unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d). |
Filing footnotes · ownership attribution and instrument terms
F1: Each Market Stock Unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 1,001 | $484.33 | $484,814.33 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 8 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,983.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F9 · price: Represents the weighted average sale price of $484.33 rounded to the nearest hundredth. The highest price at which the shares were sold was $484.85 and the lowest price at which the shares were sold was $484.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 2,193 | $483.45 | $1,060,205.85 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 7 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,984.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F8 · price: Represents the weighted average sale price of $483.45 rounded to the nearest hundredth. The highest price at which the shares were sold was $483.87 and the lowest price at which the shares were sold was $483.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 2,200 | $482.66 | $1,061,852.00 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 6 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,177.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · price: Represents the weighted average sale price of $482.66 rounded to the nearest hundredth. The highest price at which the shares were sold was $482.94 and the lowest price at which the shares were sold was $482.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 1,032 | $481.60 | $497,011.20 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,377.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: Represents the weighted average sale price of $481.60 rounded to the nearest hundredth. The highest price at which the shares were sold was $481.98 and the lowest price at which the shares were sold was $481.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 1,000 | $480.76 | $480,760.00 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,409.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: Represents the weighted average sale price of $480.76 rounded to the nearest hundredth. The highest price at which the shares were sold was $480.98 and the lowest price at which the shares were sold was $480.46. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 200 | $479.51 | $95,902.00 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,409.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: Represents the weighted average sale price of $479.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $479.98 and the lowest price at which the shares were sold was $479.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 800 | $478.74 | $382,992.00 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,609.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: Represents the weighted average sale price of $478.74 rounded to the nearest hundredth. The highest price at which the shares were sold was $478.98 and the lowest price at which the shares were sold was $478.05. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 1,174 | $477.78 | $560,913.72 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,409.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price of $477.78 rounded to the nearest hundredth. The highest price at which the shares were sold was $477.95 and the lowest price at which the shares were sold was $477.60. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:27 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,363.5582 | $93.08 | $220,000.00 |
DisclosureSEC source: 0001127602-22-016184 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,018.0305 Underlying: Common Stock · 2,363.5582 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:09 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GiftCommon Stock | 1,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-013655 · wf-form4_165221696506790.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,583.29 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Performance Stock Rights · Derivative | 40,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-003042 · wf-form4_164513423716834.xml · derivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,103 Underlying: Common Stock · 40,958 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 32,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-003042 · wf-form4_164513423716834.xml · derivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,061 Underlying: Common Stock · 32,947 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · shares: The RPSRs acquired include (i) 7,386 vested RPSRs with respect to the measurement period ended 12/31/21 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/13/19 that resulted in settlement at 122% of the target award; and (ii) 25,561 unvested RPSRs granted under the LTISP on 2/15/22 with a measurement period ending on 12/31/24. A total of 40,958 shares were issued in settlement of the 2019 RPSRs with a measurement period that ended 12/31/21, and the target award amount of 33,572 RPSRs was previously reported in connection with the grant of the 2019 RPSRs. F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Stock Rights · Derivative | 11,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-003042 · wf-form4_164513423716834.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,901 Underlying: Common Stock · 11,672 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/15/22 and will vest on 2/18/25. F1 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/15/22 and will vest on 2/18/25. F1 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/15/22 and will vest on 2/18/25. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 18,472 | $384.77 | $7,107,471.44 |
DisclosureSEC source: 0001628280-22-003042 · wf-form4_164513423716834.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,518.29 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 40,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-003042 · wf-form4_164513423716834.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,990.29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 14,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-002871 · wf-form4_164504956619746.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,229 Underlying: Common Stock · 14,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F1 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/13/19 that vested on 2/14/22. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 6,033 | $390.60 | $2,356,489.80 |
DisclosureSEC source: 0001628280-22-002871 · wf-form4_164504956619746.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,032.29 Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 14,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-002871 · wf-form4_164504956619746.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,065.29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 18:18 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 4,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-019041 · wf-form4_163233467005348.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,456 Underlying: Common Stock · 4,943 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 9/19/2018 that vested on 9/20/2021. F3 · derivative.exercise_date: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · derivative.expiration_date: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 9/19/2018 that vested on 9/20/2021. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 18:18 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 2,230 | $348.81 | $777,846.30 |
DisclosureSEC source: 0001628280-21-019041 · wf-form4_163233467005348.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,838.29 F1 · date: In accordance with the terms of the 2011 Long-Term Incentive Stock Plan ("LTISP"), because the third anniversary of the grant (September 19, 2021) fell on a weekend, the award shares vested on September 20, 2021, the next business day. The vested award shares were valued based on the Company's closing stock price on September 20, 2021. The shares will be distributed into the participant's account on September 21, 2021. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 18:18 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 4,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-019041 · wf-form4_163233467005348.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,068.29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: In accordance with the terms of the 2011 Long-Term Incentive Stock Plan ("LTISP"), because the third anniversary of the grant (September 19, 2021) fell on a weekend, the award shares vested on September 20, 2021, the next business day. The vested award shares were valued based on the Company's closing stock price on September 20, 2021. The shares will be distributed into the participant's account on September 21, 2021. F2 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 9/19/2018 that vested on 9/20/2021. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 20:24 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GiftCommon Stock | 915 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-016419 · wf-form4_162862704164712.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,125.29 Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 18:08 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,635.3933 | $75.89 | $200,000.00 |
DisclosureSEC source: 0001127602-21-018669 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,310.1273 Underlying: Common Stock · 2,635.3933 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 03, 2021 Filed May 5, 2021 17:06 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 4,916 | $352.04 | $1,730,628.64 |
DisclosureSEC source: 0001225208-21-007556 · doc4.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,040.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 4,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003098 · doc4.xml · derivative · entry 8 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,399 Underlying: Common Stock · 4,516 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F3 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F4 · derivative.expiration_date: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 2/13/18 that vested on 2/16/21. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Stock Rights · Derivative | 14,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003098 · doc4.xml · derivative · entry 7 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,915 Underlying: Common Stock · 14,776 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/16/21 and will vest on 2/16/24. F2 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/16/21 and will vest on 2/16/24. F2 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/16/21 and will vest on 2/16/24. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Performance Stock Rights · Derivative | 24,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003098 · doc4.xml · derivative · entry 6 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,114 Underlying: Common Stock · 24,108 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 33,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003098 · doc4.xml · derivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,222 Underlying: Common Stock · 33,653 shares Expires not disclosed F1 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 10,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003098 · doc4.xml · nonDerivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,956.29 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 2,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003098 · doc4.xml · nonDerivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,315.29 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 4,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003098 · doc4.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,352.29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:44 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 24,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003098 · doc4.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,836.29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Mar 1, 2021 13:49 UTC Amendment | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 33,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003993 · doc4a.xml · derivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,222 Underlying: Common Stock · 33,653 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant valuation of performance measurement period ("measurement period"). F2 · shares: The RSPRs acquired include (i) 497.2 vested RPSRs with respect to the measurement period ended 12/31/20 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/13/18 that resulted in settlement at 105% of the target award; (ii) 650.8 vested RPSRs with respect to the measurement period ended 12/31/20 acquired due to settlement of the RPSRs granted under the LTISP on 9/19/18 that resulted in settlement at 105% of the target award; and (iii) 32,505 unvested RPSRs granted under the LTISP on 2/16/21 with a measurement period ending on 12/31/23. A total of 24,108 shares were issued in settlement of the 2018 RPSRs with a measurement period that ended 12/31/20, and the target award amount of a total of 22,960 RPSRs was previously reported in connection with the grants of the 2018 RPSRs. F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant valuation of performance measurement period ("measurement period"). F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant valuation of performance measurement period ("measurement period"). Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,477.7007 | $80.72 | $200,000.00 |
DisclosureSEC source: 0001127602-20-018496 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,591.502 Underlying: Common Stock · 2,477.7007 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:25 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 113.8013 | $69.92 | $7,956.99 |
DisclosureSEC source: 0001127602-20-011294 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113.8013 Underlying: Common Stock · 113.8013 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:55 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 4,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002993 · doc4.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,139 Underlying: Common Stock · 4,465 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 2/17/17 that vested on 2/18/2020. F4 · derivative.exercise_date: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · derivative.expiration_date: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 2/17/17 that vested on 2/18/2020. F5 · balance_after: Total amount includes 11,453 RSRs granted under the LTISP on 2/12/20 that will vest on 2/12/23; 14,227 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 4,943 RSRs granted under the LTISP on 9/9/18 that will vest on 9/9/21; and 4,516 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:55 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 2,014 | $372.42 | $750,053.88 |
DisclosureSEC source: 0001225208-20-002993 · doc4.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,728.29 F1 · date: In accordance with the terms of the 2011 Long-Term Incentive Stock Plan ("LTISP"), because the third anniversary of the grant (February 17, 2020) fell on a holiday, the award shares vested on February 18, 2020, the next business day. The vested award shares were valued based on the Company's closing stock price on February 18, 2020. The shares will be distributed into the participant's account on February 19, 2020. F3 · shares: Shares surrendered to issuer in payment of tax liability in connection with vesting of RSRs in accordance with Rule 16b-3(e). Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:55 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 4,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002993 · doc4.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,742.29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: In accordance with the terms of the 2011 Long-Term Incentive Stock Plan ("LTISP"), because the third anniversary of the grant (February 17, 2020) fell on a holiday, the award shares vested on February 18, 2020, the next business day. The vested award shares were valued based on the Company's closing stock price on February 18, 2020. The shares will be distributed into the participant's account on February 19, 2020. F2 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 2/17/17 that vested on 2/18/2020. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:30 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Stock Rights · Derivative | 11,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002420 · doc4.xml · derivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,604 Underlying: Common Stock · 11,453 shares Expires not disclosed F7 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F7 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F7 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F8 · balance_after: Total amount includes 11,453 RSRs granted under the LTISP on 2/12/20 that will vest on 2/12/23; 14,227 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 4,943 RSRs granted under the LTISP on 9/19/18 that will vest on 9/19/21; 4,516 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; and 4,465 RSRs granted under the LTISP on 2/17/17 that will vest on 2/18/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:30 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Performance Stock Rights · Derivative | 12,704.44 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002420 · doc4.xml · derivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,569 Underlying: Common Stock · 12,704.44 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 119% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. F3 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F6 · balance_after: Total amount includes 27,037 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 33,572 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; 13,016 RPSRs granted on 9/19/18 with a measurement period ending on 12/31/20; and 9,944 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:30 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 29,065.44 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002420 · doc4.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,273.44 Underlying: Common Stock · 29,065.44 shares Expires not disclosed F3 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F4 · shares: The RPSRs acquired include (i) 2,028.44 vested RPSRs with respect to the measurement period ended 12/31/19 acquired due to settlement of the 2017 RPSRs held at 119% of the target award and (ii) 27,037 unvested RPSRs granted under the LTISP on 2/12/20 with a measurement period ending on 12/31/22. F3 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F5 · balance_after: Total amount includes 12,704.44 vested RPSRs granted under the LTISP on 2/17/17 with a measurement period ended on 12/31/19; 27,037 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 33,572 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; 13,016 RPSRs granted on 9/19/18 with a measurement period ending on 12/31/20; and 9,944 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:30 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 5,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002420 · doc4.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,277.29 F2 · shares: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e) Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:30 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 12,704.44 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002420 · doc4.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,599.29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 119% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:03 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 2,732 | $353.19 | $964,915.08 |
DisclosureSEC source: 0001225208-19-010726 · doc4.xml · nonDerivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,894.85 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: Represents the weighted average sale price of $353.19 rounded to the nearest hundredth. The highest price at which the shares were sold was $353.67 and the lowest price at which the shares were sold was $352.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:03 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 1,975 | $354.15 | $699,446.25 |
DisclosureSEC source: 0001225208-19-010726 · doc4.xml · nonDerivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,626.85 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: Represents the weighted average sale price of $354.15 rounded to the nearest hundredth. The highest price at which the shares were sold was $354.62 and the lowest price at which the shares were sold was $353.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:03 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 1,400 | $352.09 | $492,926.00 |
DisclosureSEC source: 0001225208-19-010726 · doc4.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,601.85 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: Represents the weighted average sale price of $352.09 rounded to the nearest hundredth. The highest price at which the shares were sold was $352.485 and the lowest price at which the shares were sold was $351.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:03 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 730 | $355.21 | $259,303.30 |
DisclosureSEC source: 0001225208-19-010726 · doc4.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,001.85 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price of $355.21 rounded to the nearest hundredth. The highest price at which the shares were sold was $355.60 and the lowest price at which the shares were sold was $354.85. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:22 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 5,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-003290 · doc4.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,151 Underlying: Common Stock · 5,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 2/17/16 that vested on 2/19/19. F4 · derivative.exercise_date: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · derivative.expiration_date: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 2/17/16 that vested on 2/19/19. F5 · balance_after: Total amount includes 14,227 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 4,943 RSRs granted under the LTISP on 9/19/18 that will vest on 9/19/21; 4,516 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; and 4,465 RSRs granted under the LTISP on 2/17/17 that will vest on 2/17/20. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:22 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 2,601 | $287.35 | $747,397.35 |
DisclosureSEC source: 0001225208-19-003290 · doc4.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,731.85 F1 · date: In accordance with the terms of the 2011 Long-Term Incentive Stock Plan ("LTISP"), because the third anniversary of the grant (February 17, 2019) fell on a weekend, the award shares vested on February 19, 2019, the next business day. The vested award shares were valued based on the Company's closing stock price on February 19, 2019. The shares will be distributed into the participant's account on February 20, 2019. F3 · shares: Shares surrendered to issuer in payment of tax liability in connection with vesting of RSRs in accordance with Rule 16b-3(e). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:22 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 5,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-003290 · doc4.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,332.85 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: In accordance with the terms of the 2011 Long-Term Incentive Stock Plan ("LTISP"), because the third anniversary of the grant (February 17, 2019) fell on a weekend, the award shares vested on February 19, 2019, the next business day. The vested award shares were valued based on the Company's closing stock price on February 19, 2019. The shares will be distributed into the participant's account on February 20, 2019. F2 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the LTISP on 2/17/16 that vested on 2/19/19. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.